INTRODUCTION
Long ignored as vestigial organelles, primary cilia have now been established as sensory antennae for a wide variety of cells. These subcellular compartments are primarily composed of microtubule-based axonemes, which are templated from basal bodies and ensheathed by the specialized ciliary membrane. The axoneme is assembled and maintained by a conserved process called intraflagellar transport (IFT) (Rosenbaum and Witman, 2002) , whereas the ciliary membrane organizes signaling receptors fundamental for sensation (Pazour and Bloodgood, 2008) . This is most apparent in the case of modified cilia; for example, olfactory neuronal cilia house olfactory G-protein-coupled receptors (GPCRs) and respond to odorants, whereas the vertebrate photoreceptor outer segments mediate phototransduction by opsins. Similarly, primary cilia in neurons respond to a wide variety of neuroendocrine signals via ciliary GPCRs. The full complement of ciliary receptors and their downstream effectors thus determine the sensory signaling of cells in specific contexts.
Graded morphogen signals provide spatiotemporal information organizing cellular differentiation in many developmental contexts. Particularly, in the vertebrate neural tube, a gradient of Shh, secreted from the ventrally located notochord and floor plate, patterns the ventral neuroepithelium into five progenitor domains that generate distinctive neuronal subtypes (Ericson et al., 1997) . In the absence of Shh signaling, ventral neural cell fates are lost (Chiang et al., 1996) . The primary cilium is fundamentally important in transducing Shh signals in these neuroepithelial cells (Huangfu et al., 2003) . Mutants affecting ciliary assembly exhibit loss of the ventral cell types specified by high levels of Shh. The genes disrupted in these mutants encode components of the IFT machinery, including the IFT-B complex (implicated in anterograde IFT), as well as the anterograde and retrograde IFT motors (Goetz and Anderson, 2010) . Paradoxically, mutations in the IFT-A complex (implicated in retrograde IFT) result in increased Shh signaling in the caudal neural tube. Null or hypomorphic alleles of IFT-A subunits (Thm1/Ift139 alien , Ift122 sopb , and Ift144 twt ) exhibit dorsal expansion of the floor plate, V3 progenitor, and motor neuron domains (Liem et al., 2012; Ocbina et al., 2011; Qin et al., 2011; Tran et al., 2008) . Alleles resulting in severe disruption of the IFT-A complex (Ift144 dmhd or combined mutations of two IFT-A subunits) result in strongly disrupted ciliary morphology. Although neural tube genes characteristic of the highest levels of Shh signaling (floor plate and V3 progenitors) fail to be induced in these mutants, there is a dorsal expansion of genes that require intermediate levels of signaling (motor neurons) (Liem et al., 2012) . The opposing neural tube phenotypes of IFT-A from other IFT mutants suggest that the IFT-A complex has additional ''preciliary'' functions in addition to its postulated role in retrograde IFT.
The Shh signaling pathway requires two branches: a basal repression mechanism that switches ''off'' the target genes and a Shh ligand-dependent switch for turning these targets ''on.'' The primary cilium in the vertebrate neuroepithelial cells acts as a regulatable platform coordinating these opposing switches. In the absence of Shh, Gli transcription factors, which are the key effectors of the pathway, are proteolytically processed to Gli repressor forms (GliRs) (Jiang and Struhl, 1998; Wang et al., 2000) . Upon exposure to Shh, production of GliRs is blocked, and activated Gli transcription factors (GliAs) turn on the expression of target genes (Humke et al., 2010; Wang et al., 2000; Wen et al., 2010) . The cAMP-activated kinase, protein kinase A (PKA), functions at the base of the cilium and is pivotal in regulating the ''off'' switch by mediating the processing of Glis into GliRs (Tuson et al., 2011; Wang et al., 2000) . Hypothetically, the temporal increase in cAMP could be mediated either by adenylyl cyclases or regulation by cAMP-phosphodiesterases. However, the signals that mediate the activation of PKA and subsequent ''tuning'' of the basal repression machinery in Shh signaling remain unknown.
The key findings in our paper potentially resolve these two fundamental mysteries in Shh signaling and provide a common answer for 1) the inputs that determine cAMP-regulated PKA activation in basal repression of Shh signaling and 2) the mechanism mediating antagonism of Shh pathway by IFT-A. A clue to the second mystery became apparent in our recent discovery that the tubby family protein Tulp3 binds to the core IFT-A subcomplex (Mukhopadhyay et al., 2010) . In addition to its known role in retrograde transport, the core IFT-A subcomplex recruits TULP3 to the cilia through this direct interaction (Mukhopadhyay et al., 2010; Qin et al., 2011) . Further, TULP3 promotes trafficking of specific rhodopsin family GPCRs to cilia, which requires both its IFT-A-and phosphoinositide-binding domains (Mukhopadhyay et al., 2010) . As mutations in Tulp3 phenocopy IFT-A mutants (Norman et al., 2009; Patterson et al., 2009) , our results suggested that a GPCR could be important in the Tulp3/IFT-A-regulated antagonism of Shh signaling.
As ciliary trafficking of Smoothened (a frizzled family GPCR that positively regulates the Shh pathway) (Corbit et al., 2005; Zhang et al., 2001) is not controlled by Tulp3/IFT-A (Mukhopadhyay et al., 2010; Qin et al., 2011) , we reasoned that another GPCR could mediate the observed defects in neural tube patterning. The criteria for this GPCR would be that it is 1) localized to cilia, 2) regulated by Tulp3/IFT-A, 3) conserved among vertebrates, 4) expressed early during neural tube development, and 5) a negative regulator of the Shh pathway. Here, we describe Gpr161, a rhodopsin family GPCR, which satisfies all of these criteria. Furthermore, constitutive activity of Gpr161 increases cellular cAMP levels, suggesting it to be a candidate GPCR for establishing the basal cAMP gradient and activation of PKA. Lastly, Shh signaling results in internalization of Gpr161 from cilia, preventing its activity.
RESULTS

The Orphan GPCR Gpr161 Localizes to the Primary Cilia
We conducted a preliminary screen to identify ciliary GPCRs expressed early during mouse embryonic development by transfecting C-terminal green fluorescent protein (GFP) fusions of candidate GPCRs in cultured IMCD3 cells. We found that the GPCR previously implicated in the vacuolated lens mouse, Gpr161 (Matteson et al., 2008) , was localized to the primary cilia. To determine the endogenous localization of this receptor, we developed an affinity-purified rabbit polyclonal antibody against a C-terminal peptide of Gpr161. Using this antibody, we could detect Gpr161 in the cilia of a variety of cultured ciliated cells, including IMCD3 cells, E10.5 (or later) mouse embryonic fibroblasts (MEF) ( Figure 1A) , and NIH 3T3 fibroblasts, and we could detect it weakly in retinal pigmented epithelial cell lines (RPE-hTERT) (data not shown). Staining for the GPCR upon knockdown of Gpr161 using siRNAs or in E10.0 Gpr161 knockout MEFs (see later) abrogated ciliary staining, showing that the antibody was specific ( Figure 1B and Figure S1A available online). We were also able to detect this receptor in virtually all cilia of cultured E16 mouse hippocampal neurons and to detect it broadly in the cilia of pyramidal neurons in the CA1/CA2 regions of adult mouse hippocampus (Figures 1A and S1B) . Thus, Gpr161 is localized endogenously to the primary cilia of a wide variety of ciliated cells, fulfilling the first of our criteria.
Gpr161 Localizes to the Cilia in a Tulp3-and IFT-A-Dependent Manner
We previously demonstrated that Tulp3 directs ciliary localization of a subset of rhodopsin family GPCRs using heterologous cultured cell lines (Mukhopadhyay et al., 2010) . We therefore tested whether Tulp3 also regulates localization of endogenous Gpr161. Upon knockdown of Tulp3 using siRNA in IMCD3 cells, ciliary localization of Gpr161 was severely reduced (Figure 1B) . The IFT-A core complex (comprised of Ift144, Ift140, and Ift122) binds to Tulp3 and provides ciliary access to Tulp3 (Mukhopadhyay et al., 2010) . We cultured Ift122 null (Ift122 sopb ) and wild-type primary MEFs isolated from E10.5 embryos (Qin et al., 2011) and determined whether Gpr161 localization to the cilia was affected. Whereas Gpr161 was localized to $50% cilia in the wild-type cells, its localization was severely reduced in the cilia of Ift122 sopb MEFs (Figures 1A and 1C) . This suggests that the ciliary localization of Gpr161 requires Tulp3 and IFT-A and fulfils another of our criteria for a candidate GPCR.
The Third Intracellular Loop of Gpr161 Is Both Necessary and Sufficient for Its Ciliary Localization
To determine the minimal sequence required for ciliary localization of Gpr161, we examined phylogenetically related GPCRs. Gpr161 is a class A rhodopsin family GPCR, highly conserved among vertebrates, and most closely related to another orphan receptor, Gpr101 ( Figures 1D and S1C ). Both are closely related to a1 adrenergic receptors (Adra1a, Adra1b, and Adra1d; Figure S1C ). GPR101 is not localized to the cilia ( Figure 1E ), and the third intracellular loops and the C termini are most divergent between GPR101 and Gpr161. Deleting a portion of the third intracellular loop of Gpr161 prevented its localization to the cilia, suggesting this region to be necessary (Figures 1D and 1E) . Furthermore, swapping the third intracellular loop of GPR101 with that of Gpr161 resulted in trafficking to the cilia, (legend continued on next page)
suggesting this region to be sufficient for ciliary localization ( Figure 1E ). Site-directed mutagenesis of conserved residues in the third intracellular loop of Gpr161 fine mapped the minimal sequence to five amino acids ((I/V)KARK; referred to as ''mut1'' region in Figure 1D ), a motif different from previously published ciliary localization sequences (Berbari et al., 2008) (Figures 1D  and 1E ).
Complete Loss of Gpr161 in the Mouse Leads to Midgestation Lethality
The vacuolated lens (vl) mutation was previously reported as a hypomorphic allele of Gpr161, which arose spontaneously in an inbred background (Matteson et al., 2008; Wilson and Wyatt, 1986) . This mutation results in lethality in $50% of the vl/vl mice, showing lumbar-sacral spina bifida. The surviving adult vl/vl mice display congenital cataracts and vacuolation in the lens. Positional cloning indicated a deletion mutation that truncates the C-terminal tail of Gpr161 (Matteson et al., 2008 (Shimamura et al., 1995) . Craniofacial defects were identifiable as early as the 8-10 somite stage (Figures S2D-S2D' and S2E-S2E') and bore a striking resemblance to embryos lacking Suppressor of fused (Sufu) (Svä rd et al., 2006; Wang et al., 2010) . The developing spinal cord was closed in the majority of the embryonic axis except in the most caudal regions ( Figure 2B' ). In addition, there was no sign of limb morphogenesis even by E10.0 (E9.5: Figure 2B') , and the apical ectodermal ridge of the limb bud, marked by Fgf8, was absent (Figures S2I-S2I'). In zebrafish, morpholinomediated knockdown of Gpr161 results in aberrant looping of the heart tube (Leung et al., 2008) . In contrast, directionality of cardiac looping was not affected in Gpr161 knockout embryos, and up until E10.0, cardiac contractions were observed. The heterozygous embryos had no characteristic defects and essentially resembled wild-type embryos.
Expression of Gpr161
Due to the relatively low-level abundance of the Gpr161 transcript, we analyzed the expression pattern of Gpr161 using radiolabeled riboprobes. As reported previously, using digoxigenin labeled probes, we found that Gpr161 is expressed ubiquitously at low levels in E8.5 and E9.5 embryos (Figures S2C, S2J-S2J', and S2K-S2K') (Matteson et al., 2008) . However, by E10.5, it was expressed prominently in the neural tube . At later embryonic stages (E12.5 and E15.5), Gpr161 was expressed predominantly in the brain, spinal cord, and dorsal ganglia and was weakly expressed in the hindlimb ( Figures 2F-2F ''). Contrary to the previous report (Matteson et al., 2008) , we did not detect Gpr161 enrichment in the lateral neural folds but detected it instead throughout the neural tube ( Figures 2E, 2F , and S2J-S2L). We also detected low levels of expression in a variety of tissues, including the kidney stroma and retina at E15.5 (data not shown). In summary, Gpr161 was expressed broadly in the nervous system throughout development, satisfying another of our criteria.
Gpr161 Knockout Embryos Exhibit Increased Shh Signaling
As the ciliary localization of Gpr161 is dependent on IFT-A/Tulp3 (Mukhopadhyay et al., 2010; Qin et al., 2011) , we tested whether Shh signaling is impacted in Gpr161 mutants by analyzing the expression of direct transcriptional targets of the Shh pathway, Patched1 (Ptch1, the gene encoding the receptor for Shh) and Gli1. We detected increased levels of both transcripts and increased Gli1 protein levels in the knockout embryos as early as the 10-12 somite stage (E9.5: Figures 3A and 3B; E8.5: Figures S3A and S3B). We also examined embryonic expression of these targets by RNA in situ hybridization. In the wild-type neural tube, these targets are expressed ventrally in response to Shh signaling. In Gpr161 mutants, Ptch1 and Gli1 expression were additionally detected ectopically in the dorsal regions of the neural tube as early as the 10-12 somite stage (Gli1: Figure 3C ; Ptch1: Figures 3E and 3F ). It is possible that this increase in expression of target genes results from increased production of the Shh ligand. However, Shh expression was confined to its normal domains (the notochord and floor plate at E9.5 or notochord at E8.5) ( Figure 3D ), with expanded domains only in the caudal neural tube ( Figure S3F ). We also looked at expression patterns for the other Gli transcription factors. Expression of Gli3 is normally restricted to dorsal regions by Shh signaling, and this gene showed reduced overall expression in Gpr161 mutants ( Figure S3E ). The expression domain of Gli2 was roughly similar between genotypes (data not shown). Similarly, there was a modest decrease in Gli3 transcript levels, but not of Gli2 ( Figure S3C ). Gli3 RNA expression is downregulated by Shh signaling (Bai et al., 2004; Wang et al., 2000) , and the changes in Gli3 RNA levels in the Gpr161 mutants are likely to be a consequence of activation of the Shh pathway. In summary, these data indicate that Gpr161 mutants experience elevated levels of Shh pathway activity.
(D) Multiple sequence alignment of the third intracellular loop of the vertebrate homologs of Gpr161. Site-directed mutants of conserved regions are shown below.
(E) The ciliary localization signal of Gpr161 is both necessary and sufficient for ciliary localization. IMCD3 cells were transfected with the indicated constructs and checked for ciliary localization in transfected cells. +++ refers to >70% cilia consistently strongly positive for Gpr161, and ++ refers to $70% cilia positive for Gpr161 in transfected cells. As it is difficult to correctly determine nontransfected cells in a population, the distribution of transfected cells is provided as a qualitative estimate. See also Figure S1 . (legend continued on next page) Gpr161 Knockout Mice Exhibit a Ventralized Neural Tube IFT-A and Tulp3 mutant embryos show an expansion of Shhdependent ventral cell types in the developing neural tube (a ''ventralization'' phenotype) (Norman et al., 2009; Ocbina et al., 2011; Patterson et al., 2009; Qin et al., 2011; Tran et al., 2008) . We next ascertained whether Gpr161 knockout embryos are similarly affected. By E9.5, Shh-dependent ventral cell types were ectopically specified at the expense of lateral and dorsal cell types, throughout the spinal cord and hindbrain of Gpr161 (E and F) RNA in situ hybridization with radiolabeled antisense (E and F), or sense riboprobes (E' and F') for Gpr161 in transverse sections of E10.5 (E and E') and sagittal sections of E12.5 (F and F') in the wild-type background. Cresyl violet staining of the corresponding sections is shown in E'' and F''. Genotypes of embryos are as follows: wild-type (+/+) and Gpr161 knockout (À/À). Abbreviations: FB, forebrain; HB, hindbrain; HL, hind limb; Lb, limb bud; MB, midbrain; NT, neural tube; OV, optic vesicle. Scale for (A) and (B), 1 mm; (A'), (A''), (B'), (B''), (D), and (D''), 0.5 mm; (E-E'') and (F-F''), 2.5 mm. See also Figure S2 . 
trunk region). Ventral is to the bottom in (C), (D), and (F). The extent of hybridization is marked by lateral bars in (C) and (F).
In all panels, genotypes are marked as: wild-type (+/+); Gpr161 heterozygous (+/À); and Gpr161 knockouts (À/À). *p < 0.05, **p < 0.01, and ***p < 0.001 with respect to corresponding wild-type levels. Scales for (E), 1 mm; scales for (C), (D), and (F), 100 mm. See also Figure S3 .
mutants. Specifically, floor plate progenitors expressing FoxA2, p3 progenitors expressing Nkx2.2, pMN progenitors expressing Olig2, and p3/pMN/p2 progenitors expressing Nkx6.1 showed enlarged expression domains, expanding into comparatively more dorsal regions and showing notable intermingling of markers ( Figure 4 and Movies S1, S2, S3, and S4). Shh signaling also inhibits the specification of lateral and dorsal neural cell types. In Gpr161 mutants, markers for these cell types were either strongly downregulated (Pax7) or were expressed in dorsally restricted domains (Pax6) (Figure 4 and Movies S5 and S6). We could detect defects in dorso-ventral patterning as early as the 8-10 somite stage, at a time when the Nkx6.1-and FoxA2-expressing domains were expanded dorsally in the neural tube ( Figure S4 ). This expansion was followed by a further expansion of the Olig2-expressing domain by the 10-12 somite stage ( Figure S4 ). Although similar to mouse embryos with IFT-A complex and Tulp3 mutations, the ventralization phenotype was not only limited to the caudal neural tube but instead extended throughout the spinal cord and the hindbrain (Movies S1, S2, S3, S4, S5, and S6).
Gpr161 Knockout Mice Exhibit Gli3/Gli2 Processing Defects In the absence of Shh ligand, PKA-mediated phosphorylation of Gli3 results in its limited proteolysis into Gli3R (Jiang and Struhl, 1998; Wang et al., 2000) . In Gpr161 mutant embryos, the extent of Gli3 processing into Gli3R at E8.5 (and later stage) wholeembryonic extracts was strongly decreased compared to wild-type (E9.5: Figure 3B ; E8.5: Figure S3B ), suggesting that Gpr161 directs processing of Gli3 into Gli3R. Shh signaling inactivates PKA kinase activity, preventing this limited proteolysis. Subsequently, activated full-length Gli proteins are formed that are unstable (Chen et al., 2009; Humke et al., 2010; Jia et al., 2009; Wang et al., 2010; Wen et al., 2010) . In Gpr161 mutants, the full-length forms of both Gli3 and Gli2 were moderately reduced (E9.5: Figures 3B and S3D ; E8.5: Figure S3B ), similar to but less severe than in mutants with complete loss of PKA activity (PKA null) or Sufu (Tuson et al., 2011; Wang et al., 2010) . This suggests that the absence of Gpr161 leads to activation of the Gli proteins, which is consistent with the strongly ventralized neural plate of the mutants. In summary, the Gpr161 mutants exhibit a ventralized neural tube phenotype and Gli processing defects suggestive of increased Shh signaling, satisfying the final requirement of our criteria. (Norman et al., 2009; Ocbina et al., 2011; Qin et al., 2011) . Mice mutants for Smo exhibit embryonic arrest by E9.5 and defects in the ventral midline, including cyclopia and dorsalization of the neural tube (Zhang et al., 2001) . The growth retardation defect caused by the disruption of Smo was completely suppressed in Smo/ Gpr161 double mutants, and the craniofacial abnormalities were similar to that of Gpr161 single mutants ( Figure 5A ). Similarly, the expansion of ventral identity markers (Nkx2.2, Olig2, and Nkx6.1) and dorsal restriction of Pax6 occurred in Smo/ Gpr161 double mutants as in Gpr161 single mutants ( Figures  5A and S5A) . Although the immunostaining of the marker for floor plate progenitors, FoxA2, in the double mutant was weaker than the Gpr161 single mutant, clear ectopic expression was evident in the dorsal neural tube ( Figure S5A ). These floor plate progenitors require maximal Shh signaling, and the inability of full restitution in the double knockout (in comparison to the Gpr161 single mutant) suggests lack of fully active Shh signaling in the absence of Smo. Mostly, however, similar to Tulp3 and IFT-A, Gpr161 is epistatic to Smo. Thus, the ventralization phenotype in Gpr161 mutants occurs largely independently of Smo and suggests its role in the basal repression machinery of Shh signaling. See also Figure S4 and Movies S1, S2, S3, S4, S5, and S6.
Shh Pathway Activation in
in defective ciliogenesis and a loss of ventral cell types specified by high levels of Shh in the neural tube (Huangfu et al., 2003) . However, Sufu acts as a negative regulator of mammalian Shh signaling independent of cilia (Chen et al., 2009; Jia et al., 2009) . We investigated whether the Gpr161 mutant phenotype is dependent on cilia by generating Kif3a/Gpr161 double mutants. Kif3a single mutants are smaller than wild-type embryos and arrest around E9.5 (Marszalek et al., 1999) . The general morphology and neural patterning of Kif3a/Gpr161 double mutants resembled that of Kif3a single mutants ( Figures  5B and S5B) . At the E9.5 stage, the increase in Gli1 protein levels and Gli1/Ptch1 transcript levels in Gpr161 knockout E9.5 embryos were suppressed in the Gpr161/Kif3a double-knockout embryos ( Figures 5C, 5D , and S5C). In addition, both the Kif3a mutants (Humke et al., 2010; Wen et al., 2010) and the Gpr161/Kif3a double mutants had significantly lower levels of Gli3R but equivalent levels of Gli3FL compared to wild-type or Gpr161 heterozygous embryos ( Figure 5D ). Thus, the activation of the Shh pathway resulting from disruption of Gpr161 depends on kinesin II. Although kinesin II is known to play other roles in embryos (not shown; Marszalek et al., 1999) . Magnifications for whole-embryo images: $322 in (A). Scale for whole-embryo images in (B), 1 mm; scale for cryosections in (A) and (B), 100 mm.
(C) Gli1 and Ptch1 transcript levels in wholeembryo lysates at E9.5. Individual estimations were done in triplicate and are represented as mean ±SD; *p < 0.001 with respect to corresponding wild-type levels.
(D) Immunoblotting for Gli1, Gli3, and a-tubulin in whole-embryo lysates at E9.5. Abbreviations as in Figure 3B . In (C) and (D), respective genotypes are marked as: wild-type (+/+); heterozygous (+/À); and knockouts (À/À). See also Figure S5 .
addition to IFT (Bananis et al., 2004) , its role in neural tube patterning is primarily mediated through primary cilia, suggesting the parsimonious model that lack of Gpr161 activates Shh pathway in this compartment. The morphology of cilia was not grossly affected in the Gpr161 knockout embryos or in E10.0 knockout MEFs ( Figures S5D and S5E) . A similar test of dependence of the Gpr161 phenotype on the central Shh pathway regulator, Gli2, was not possible because of close genetic linkage (Extended Experimental Procedures).
Gpr161 Is Removed from the Cilia upon Treatment with Shh
Because of the elaborate coupling between spatial patterning and timing in the developing neural tube, we considered the model that the Gpr161 pathway itself would need to be inactivated as Shh signaling became fully activated. We tested the most direct mechanism, wherein activation of Shh would directly inactivate Gpr161 in cilia. Remarkably, treatment with Shh resulted in complete loss of endogenous Gpr161 from cilia within 2 hr in IMCD3 cells ( Figure 6A ). Treatment with SAG or purmorphamine, which directly activate Smo (Sinha and Chen, 2006) , was also equally effective in removing Gpr161
LAP from cilia of NIH 3T3 cells ( Figures 6B and 6C) . Furthermore, treatment with the oxysterol 20a-hydroxycholesterol, which can act as a Smo agonist, but not with the related inactive oxysterol (7b-hydroxycholesterol) (Nachtergaele et al., 2012) , had similar effects ( Figure 6B ). The effect of Shh treatment on receptor removal was suppressed in the presence of the small-molecule inhibitors of Smo, HhAntag (Frank-Kamenetsky et al., 2002; Romer et al., 2004) , and cyclopamine (Chen et al., 2002) , suggesting that active Shh signaling is required for its ciliary exit ( Figures 6B, 6C , and S6A). Importantly, total Gpr161 LAP protein levels were not affected following treatment with Shh as seen by immunoblotting ( Figure S6B ). The receptor was internalized into the recycling endocytic compartment as designated by labeling with endocytosed transferrin ( Figure S6C ). Thus Shh signaling itself prevents Gpr161 signaling by removing it from cilia.
Basal Activity of Gpr161 Results in Increased cAMP Levels
The defects in Gli processing in Gpr161 mutants are strongly reminiscent of similar defects in PKA null (Tuson et al., 2011) or Sufu mutants (Wang et al., 2010) and could be mediated by either PKA or Sufu. In order to discriminate between these possibilities, we investigated Gpr161-mediated downstream signaling. Agonist-independent constitutive signaling has now been observed for a wide variety of GPCRs (Leurs et al., 1998; Seifert and Wenzel-Seifert, 2002) . In the absence of a known ligand, we looked for constitutive activity of Gpr161 by generating doxycycline-inducible stable cell lines expressing the untagged wild-type receptor. We next subjected these cells to TR-FRET (time-resolved fluorescence resonance energy transfer) cellbased assays for estimating second messengers or byproducts of GPCR signaling (cAMP and inositol phosphate IP 1 , a breakdown product of IP 3 ). Adenylyl cyclases are primarily activated by Ga s , but can also be differentially regulated by Gbg or Ca 2+ (Sunahara and Taussig, 2002) , so it is important to assay downstream activation of both Ga i/o and Ga q/11 pathways, respectively. For assaying Ga i/o activity, the cells were simultaneously treated with forskolin (which activates adenylyl cyclases) to increase basal cAMP levels. To assay Ga q/11 activity, we estimated IP 1 levels. Gpr161 was strongly induced under the experimental conditions ( Figures 7C and S7B) . Out of the assay formats for measuring cAMP and IP 1 levels, we only detected a significant increase in cAMP levels in induced cells, either in the absence or presence of forskolin (T-REx-293 cells: Figures 7A and 7B ; NIH 3T3 Tet-on 3G cells: Figure S7A ). The increase in basal cAMP levels in induced cells was $40% to $70% of cAMP levels detected upon forskolin treatment in uninduced T-REx-293 and NIH 3T3 Tet-on 3G cells, respectively. As our assays rule out Ga i/o or Ga q/11 activity, Gpr161 is likely to be Ga s coupled. We tested this directly by knocking down Ga s in T-REx-293 cells using two different siRNAs. Upon treatment with either of these siRNAs, we detected less than 30% residual protein ( Figure 7D inset) and an $50% reduction in the basal cAMP activity of Gpr161, suggesting that Gpr161 is primarily coupled to Ga s (Figure 7D) . As Gpr161 overexpression and constitutive activity results in increased cAMP concentration, we predict that its major role in antagonizing Shh signaling is via activating PKA.
To construct an inactive mutant of Gpr161, we considered specific mutations previously characterized in GPCRs. The mutation V147E in the second intracellular loop (following the ''D[E]RY'' motif, DRYxxV) of the closely related hamster a1b-adrenergic receptor results in a complete loss of receptormediated signaling, whereas mutations of the homologous valine in IL8RA result in a profound impairment of its coupling to Ga i (Damaj et al., 1996; Greasley et al., 2001) . We therefore generated inducible stable lines expressing the homologous LAP were grown until confluency and then starved and treated with indicated reagents for 22 hr. Cells were immunostained for acetylated tubulin and estimated for Gpr161 LAP localization in cilia. Concentrations of chemicals are as follows: octyl-Shh (300 ng/ml), SAG (250 nM), Purmomorphamine (Purmo; 10 mM), HhAntag (HhAnt; 250 nM), 20a-hydroxycholesterol (20-OHChl; 5 mM), and 7b-hydroxycholesterol (7-OHChl; 5 mM). As the oxysterols were dissolved in chloroform (CHCl 3 ), the control for estimating their effect was adding equivalent amounts of CHCl 3 . Data are represented as mean ±SD; *p < 0.001 with respect to DMSO-or CHCl 3 -treated cells. (C) NIH 3T3 lines stably expressing Gpr161 LAP were processed with indicated reagents as in (B). Cells were immunostained for acetylated tubulin (Actub; magenta) and counterstained with Hoechst (blue). Cilia are marked by white arrows. See also Figure S6 .
valine in Gpr161 mutated to glutamate (V158E). We did not detect any increase in cAMP upon induction ( Figures 7A, 7B , and S7A), although the increase in protein levels was similar to the wild-type receptor in two separate cell lines ( Figures 7C  and S7B ), suggesting that the V158E mutation completely blocks constitutive receptor activity.
DISCUSSION
Gpr161 Is a Key Negative Regulator of Shh Signaling
Tulp3 and IFT-A mutants exhibit ventralized phenotypes in the neural tube compared to the dorsalized phenotype of other IFT machinery mutants that affect ciliary assembly. We previously showed that Tulp3 binds to the core IFT-A subcomplex and predicted that trafficking of a ciliary GPCR by Tulp3 could mediate the effect of Tulp3/IFT-A in antagonizing Shh signaling (Mukhopadhyay et al., 2010) . In the present study, we have identified such an orphan class A GPCR, Gpr161, which is conserved in vertebrates and is critical for neural tube patterning. We show that endogenous Gpr161 is localized to cilia in a wide variety of cells and requires Tulp3/IFT-A for ciliary trafficking. During mouse embryonic development, Gpr161 is expressed ubiquitously as early as E8.5 and is mostly concentrated in the developing nervous system at later stages. Most importantly, a null knockout allele for Gpr161 results in embryonic lethality by E10.5 and generally phenocopies but is more extensive than the Tulp3/IFT-A mutants by causing increased Shh signaling and ventralization throughout the developing neural tube. Thus, our results describe the role of a Tulp3/IFT-A-regulated GPCR in mammalian Shh signaling. The complete absence of limb buds in Gpr161 knockout mutants suggests that, in addition to the Shh pathway, it functions in other morphogenetic pathways that affect limb development.
Gpr161 Regulates Processing and Stability of Gli Proteins through cAMP Signaling
How does Gpr161 affect Shh signaling? Both Sufu and PKA regulate the processing and/or stability of Gli3/2 proteins. Gpr161 knockout embryos exhibit decreased processing of Gli3 into Gli3R and reduced levels of both Gli3/2 full-length proteins, which is strongly reminiscent of either PKA null or Sufu mutants, although phenotypes in these mutants are more severe (with embryonic lethality by E9-9.5 and dramatic reduction in levels of Gli3/2 full-length protein) (Tuson et al., 2011; Wang et al., 2010) . Which of these two pathways could mediate the effects of Gpr161 on Gli3 processing? First of all, Gpr161 overexpression and constitutive activity result in increased cAMP levels, which would strongly facilitate increased PKA activity, suggesting that the primary effect of Gpr161 is mediated through PKA. Our cAMP/IP 1 and Ga s knockdown assays suggest that Gpr161 is likely to be Ga s coupled. Notably, Ga s has been recently described to be present in mammalian ciliary proteome (Ishikawa et al., 2012) . Second, primary cilia are not required for Sufu to inhibit Gli activity (Chen et al., 2009; Humke et al., 2010; Jia et al., 2009) , whereas the neural tube phenotype in the Gpr161 mutant is dependent on the anterograde IFT motor kinesin II, suggesting that the effects of Gpr161 are not mediated primarily through the action of Sufu. The effect of Gpr161 (and Tulp3/IFT-A) (Norman et al., 2009; Qin et al., 2011) on ventralization of the neural tube occurs largely independent of Smo (which is critically important in the Shh-activation machinery). This also reinforces the idea that the primary effect of Gpr161 is in ''tuning'' the PKA-dependent basal repression machinery in Shh signaling by modulating cAMP levels ( Figure 7E ).
Gpr161 Internalization upon Shh Signaling
An important aspect of Shh signaling is the ''resetting'' of the ''off'' switch by removal of both Ptch1 and Gpr161 from the cilia ( Figure 7E ). Ptch1 directly binds to Shh, and this step is critical in its ciliary exit (Rohatgi et al., 2007) . In contrast, the internalization of Gpr161 occurs upon treatment with Shh or agonists of Smo, i.e., active Shh signaling. However, Gpr161 does not bind to Ptch in coimmunoprecipitation assays (data not shown). Further, in contrast to Ptch1, Gpr161 is not a transcriptional target of the Shh pathway (data not shown), and thus Gpr161 removal from the cilia constitutes a positive feedback loop restricting its function during active Shh signaling. Gpr161 is internalized into the endosomal recycling compartment upon Shh signaling and is not apparently degraded. Further studies into mechanisms of internalization of Gpr161 promise to provide us with important insights into pathways regulating GPCR levels in the ciliary compartment.
Role of Cilia as a Regulatable Platform during Shh Signaling
Although we cannot formally rule out the possibility of Gpr161 functioning in cAMP/PKA-mediated regulation of Shh signaling in the absence of cilia, the localization of both Gpr161 and Ga s in the cilia suggests them to be, at least, functional in this cellular compartment. This also brings us to the broader issue of the requirement of the primary cilium for organizing Shh signaling in vertebrates. Clearly, the components of the basal repression machinery, including both Ptch1 and Gpr161, are ciliary and are actively removed from cilia in a Shh-dependent manner. In this case, the cilia probably acts as a platform amenable to rapid ''resetting.'' The cilium also acts as a trafficking platform for Gli3/ 2 processing (Haycraft et al., 2005; Humke et al., 2010; Wen et al., 2010) . Besides, PKA is localized to the cilium base and plays an essential role in integrating Shh signals (Tuson et al., 2011) for Gli processing. As basal activity of Gpr161 causes increased cellular cAMP levels, and it localizes to the cilium in the absence of Shh, it is a candidate GPCR for establishing this basal cAMP gradient. The identification of the ciliary localization motif and our ongoing studies on the internalization and activation motifs in Gpr161 will provide us with critical parameters to test in order to address the precise role of Gpr161 in establishment of the spatiotemporal cAMP gradient and the function of cilia as a regulatable platform during vertebrate Shh signaling.
EXPERIMENTAL PROCEDURES Mouse Strains
Heterozygous mice harboring the Gpr161 allele were obtained from Taconic/ Lexicon Pharmaceuticals. The Gpr161 knockout was generated by gene Wild-type band was 345 bp, and the mutant band was 208 bp ( Figure S2B ). Targeted deletion was also confirmed by Southern analysis by Lexicon (data not shown). The heterozygous mice were bred into a C57BL6/N background and backcrossed four times. No difference in the Gpr161 mutant phenotype was observed on either the mixed background (or during crossing with other strains) or after backcrossing into the C57BL6/N background. Other mouse strains used include Smo tm1Amc (Zhang et al., 2001) and Kif3A tm1Gsn (Marszalek et al., 1999) .
Antibodies and Reagents
A C-terminal peptide from mouse Gpr161 (Cys-RGSRTLVNQRLQLQSIKE GNVLAAEQR-COOH) was used as an immunogen for raising polyclonal antibody against Gpr161 and was affinity purified using standard protocols (YenZym). Details of other antibodies, plasmids, reagents, and generation of stable cell lines are in Extended Experimental Procedures.
In Situ Hybridization, Scanning EM, Immunofluorescence, and Microscopy In situ hybridization (ISH) experiments using radiolabeled and digoxigeninlabeled probes, scanning EM, immunofluorescence of cultured cells, and embryo cryosections were performed according to standard protocols and are described in Extended Experimental Procedures.
GPCR Immunoblotting and Immunoprecipitation
T-REx-293 Gpr161 or Gpr161 V158E cells were harvested by scraping and were snap frozen in liquid N 2 . Lysis was done in a GPCR lysis buffer (1% digitonin in TBS [150 mM NaCl, 50 mM Tris, pH 7.5] with freshly added protease and phosphatase inhibitors) for an hour. After clarifying the lysate at 16,000 3 g for 10 min, equivalent amounts of low-speed supernatant were treated with 2 3 urea sample buffer (4 M urea, 4% SDS, 100 mM TrisHCl [pH 6.8], 0.2% bromophenol blue, 20% Glycerol, 200 mM DTT) at room temperature. Samples were loaded to 4%-12% Bis-Tris NuPAGE gels within 15 min and were immunoblotted using standard procedures. For immunoprecipitation experiments, T-REx-293 Gpr161 cells were transfected with C-terminal Flag-tagged pRK5-PTCH1 construct and were induced for $48 hr. After harvesting and snap-freezing cells, cells were lysed for 1 hr in the previous GPCR lysis buffer with added 0.05% cholesterol hemisuccinate (CHS) and 0.25% dodecyl maltoside (DDM) and were clarified as mentioned previously. Simultaneously, anti-FLAG M2-affinity beads were washed in TBS and were washed in 0.1 M Glycine, pH 3.5. After rewashing in TBS, the beads were added to the clarified lysates for 3 hr. The beads were washed thrice in the same lysis buffer and were treated with 2 3 urea sample buffer as mentioned above. Immunoblotting was performed for FLAG and Gpr161. For preparation of the lysis buffers, 1% digitoinin was added to TBS from a 10% stock and was used within 7 days of preparation. The CHS/DDM 40 3 stock solution was prepared by sonicating during solubilization. Embryos were processed for Gli1/2/3 immunoblotting as described previously .
TR-FRET cAMP and IP 1 Assays
To measure the activation of G s/i/o and G q/11 , we used cell-based TR-FRETbased cAMP dynamic 2 and IP-One HTRF commercial assays to measure cAMP and IP 1 , respectively (Cisbio). The TR-FRET assay eliminates the background noise due to FRET-based estimation of signals. Besides, the use of long-lived fluorophores (in this case, lathanides), combined with time-resolved detection (a delay between excitation and emission detection), minimizes prompt intrinsic fluorescence interferences (Degorce et al., 2009 were induced for 24 hr with doxycycline in serum starvation media (containing 0.5% FBS). For the cAMP assays, cells were finally treated with the nonselective phosphodiesterase inhibitor IBMX (1 mM) with or without addition of forskolin (2 mM) as mentioned in the legends ( Figures 7A and S7A ). For the IP 1 assay, cells were finally treated with IP stimulation buffer (Cisbio; HEPES 10 mM, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 4.2 mM KCl, 146 mM NaCl, 5.5 mM glucose, LiCl 50 mM [pH 7.4]) for 45 min. Individual treatments were run in each experiment in triplicate. The final FRET counts were recorded using an EnVision 2103 multiplate reader (Perkin Elmer). Standard curves were generated using least-squares fitting method (with R 2 value > 0.99), and values for unknowns were interpolated using Graphpad Prism 5.
Statistical Analyses
Statistical analyses were performed using one-way analysis of variance (ANOVA) and Tukey-Kramer's post hoc multiple comparison tests between all possible pairs in each data set ( Figures 5C, 6B , and S6), whereas Student's t test was used for comparing groups ( Figures 1B, 1C , 3A, 3B, 7A, 7B, 7D, S2, and S3) using JMP 9 statistical analyses package.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, and six movies and can be found with this article online at http://dx.doi. org/10.1016/j.cell.2012.12.026.
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We thank Kathryn Anderson and Jonathan Eggenschwiler for advice on mouse assays throughout the course of this work and kind gifts of reagents. We are indebted to the Genentech mouse facility and core genotyping facilities for (D) T-REx-293 cells stably expressing untagged Gpr161 were transfected with indicated siRNAs (100 nM) for 96 hr, induced for last 24 hr, and subjected to TR-FRET cAMP assays. Levels of cAMP in each siRNA-transfected cohort were normalized as in (A). Data are average from two independent experiments and are represented as mean ±SD; *p < 0.05 with respect to control siRNA-treated induced cells. Inset shows levels of Ga s and a-tubulin detected by immunoblotting in uninduced cells upon siRNA transfection for 96 hr. The Ga s antibody detects both large and small Ga s isoforms (Bray et al., 1986) , and the relative levels of the predominant smaller isoform are given below the immunoblots. (E) Model for the role of Gpr161 in the Shh pathway. In the absence of Shh, Gpr161 is localized to the cilia in a Tulp3/IFT-A-dependent manner. The Gpr161 knockout phenocopies Tulp3/IFT-A mutants by causing increased Shh signaling in the neural tube. Constitutive Gpr161 activity increases cAMP levels, which is reduced upon knockdown of Ga s , suggesting it to be a Ga s -coupled receptor. The increase in cAMP levels could activate PKA and could explain the decreased Gli3R levels in the Gpr161 mutant. Ligand binding could potentially modulate the constitutive activity of this receptor and remains currently unknown (question mark). In the presence of Shh, Gpr161 is removed and internalized from the cilia, preventing its activity. Abbreviations: Gli3A, Gli3 activator; Gli3FL, Gli3 full length; Gli3R, Gli3 repressor. See also Figure S7 . 
